Why did Fauci CHEER when hydroxychloroquine was used in 2013 for MERS, but is now skeptical for coronavirus?
by: Ethan Huff
NaturalNews.com
Sunday, April 12, 2020
After President Donald Trump mentioned during a recent press conference the potential benefits of hydroxychloroquine for treating the Wuhan coronavirus (COVID-19), Anthony Fauci from the National Institute of Allergy and Infectious Diseases (NIAID) quickly piped in that the remedy supposedly isn’t proven, and that people shouldn’t think of it as a “knockout drug.” So why, then, did he praise this very same drug back in 2013 as a treatment for the MERS coronavirus, a relative of COVID-19?
At the time, Barack Obama was occupying the White House, and an NAIAD study conducted by a guy named Darryl Falzarano found that an antiviral cocktail containing hydroxychloroquine showed incredible promise in vitro for preventing viral replication. Fauci jumped at the chance to praise the discovery, announcing that it was “particularly encouraging” because these drugs are “widely available,” meaning they can get into the hands of people who need them quickly and easily.
However, now that Trump and his administration are in charge, Fauci is singing a much different tune. Rather than express enthusiasm for the many cases of the Wuhan coronavirus (COVID-19) that have already been successfully treated with hydroxychloroquine, Fauci felt the need to throw a wet blanket over the whole thing and override Trump’s announcement in a stunning display of disrespect.
“You’ve got to be careful when you say ‘fairly effective,’” Fauci shot back at Trump after the president suggested, based on Fauci’s own statements from seven years ago, that hydroxychloroquine demonstrated effectiveness against SARS (severe acute respiratory syndrome). “It was never done in a clinical trial that compared it to anything. It was given to individuals and felt that maybe it worked.”
The Rest…HERE
